Perillyl alcohol protects against ethanol induced acute liver injury in Wistar rats by inhibiting oxidative stress, NFκ-B activation and proinflammatory cytokine production

Toxicology

Volumn 279, Issue 1-3, 2011, Pages 108-114

  Khan, Abdul Quaiyoom ^a   Nafees, Sana ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Ethanol; Inflammation; Liver damage; Oxidative stress; Perillyl alcohol

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; PERILLYL ALCOHOL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; INFLAMMATION; INHIBITION KINETICS; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STOMACH TUBE;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG-INDUCED LIVER INJURY; ENZYME INHIBITORS; ETHANOL; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; MALE; MONOTERPENES; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78650026898     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.09.017     Document Type: Article

References (62)

1. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radical Biol. Med. 2002, 32:110-114.
2. Athar M., Iqbal M. Ferric nitrilotriacetate promotes N-diethylnitrosamine induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis 1998, 19:1133-1139.
3. Balunas M.J., Kinghorn A.D. Drug discovery from medicinal plants. Life Sci. 2005, 78:431-441.
4. Barthelman M., et al. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res. 1998, 15(58):711-716.
5. Belanger J.T. Perillyl alcohol: applications in oncology. Altern. Med. Rev. 1998, 3:448-457.
6. Berchtold C.M., et al. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappa-B pathway. Cancer Res. 2005, 65:8558-8566.
7. Bishop W.R., et al. Farnesyl transferase inhibitors: mechanism of action, translational studies and clinical evaluation. Cancer Biol. Ther. 2003, 2:S96-S104.
8. Broitman S.A., Wilkinson J, Cerda S., Branch S.K., et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv. Exp. Med. Biol. 1996, 401:111-130.
9. Burke Y.D., et al. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res. 2002, 22:3127-3134.
10. Carlberg I., Mannervik B. Glutathione reductase levels in rat brain. J. Biol. Chem. 1975, 250:5475-5480.
11. Claiborne A. Catalase activities. CRC Handbook of Methods in Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton. R.A. Greenwald (Ed.).
12. Crowell P.L. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 1999, 129:775S-778S.
13. da Fonseca C.O., et al. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. Surg. Neurol. Suppl. 2006, 1. 1:S1:2-1:8; (discussion S1:8-1:9).
14. Dickinson D.A., Forman H.J. Glutathione in defense and signaling: lessons from a small thiol. Ann. N.Y. Acad. Sci. 2002, 973:488-504.
15. Fernández-Checa J.C., Hirano T., Tsukamoto H., Kaplowitz N., et al. Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol 1993, 10:469-475.
16. Fernandez-Checa J.C., et al. Mitochondrial glutathione: importance and transport. Semin. Liver Dis. 1998, 18:389-401.
17. Forman H.J., et al. Redox signaling. Mol. Cell. Biochem. 2002, 234-235:49-62.
18. French S.W., et al. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxida- tion, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 1993, 58:61-75.
19. French S.W. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J. Biomed. Sci. 2001, 8:20-27.
20. Garcia-Ruiz C., et al. Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology 1995, 21:207-214.
21. Gould M.N. Cancer chemoprevention and therapy by monoterpenes. Environ. Health Perspect. 1997, 105:977-979.
22. Habig W.H., et al. GST the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
23. Iimuro Y., et al. Antibodies to tumor necrosis factor-α attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997, 26:1530-1537.
24. Jeffers L., et al. The effect of perillyl alcohol on the proliferation of human prostatic cell lines. Proc. Am. Assoc. Cancer Res. 1995, 36:303.
25. Jewell S.A., et al. Decreased hepatic glutathione in chronic alcoholic patients. J. Hepatol. 1986, 3:1-6.
26. Jollow D.J., et al. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4- bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974, 11:151-169.
27. Karlson J., et al. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. Anticancer Drugs 1996, 7:422-429.
28. Kornberg Lactic dehydrogenase of muscle. Methods in Enzymology 1955, vol. I:441-443. Academic Press, New York.
29. Kurose I., et al. Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology 1997, 112:1331-1343.
30. Lantry L.E., et al. Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J) F1 mouse lung. J. Cell. Biochem. 1997, Suppl. 27:20-25.
31. Lowry O.H., et al. Protein measurement with the phenol reagent. J. Biol. Chem. 1964, 193:2370-2378.
32. Masini A., et al. Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats. The critical role for mitochondrial reduced glutathione. Biochem. Pharmacol. 1994, 47:217-224.
33. McClain C.J., et al. Tumor necrosis factor and alcoholic liver disease. Semin. Liver Dis. 1999, 19:205-219.
34. McClain C.J., Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989, 9:349-351.
35. McClain C.J., et al. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287G:497-502.
36. Meagher E., et al. Alcohol induced generation of lipid peroxidation products in humans. Clin. Invest. 1999, 104:805-813.
37. Mills J.J., et al. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 1995, 55:979-983.
38. Mohandas J., et al. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Res. 1984, 44:5086-5091.
39. Nanji A., et al. Activation of nuclear factor κ-B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999, 30:933-943.
40. Navasumrit P., et al. Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: effects of acute and chronic ethanol exposure. Carcinogenesis 2000, 21:93-99.
41. Naveau S., et al. Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis. Gastroenterol. Clin. Biol. 2005, 29:269-274.
42. Nomura M., et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced NFκ-B activation by tea polyphenols, (¡) - epigallocatechin gallate, and theaflavins. Carcinogenesis 2000, 21:1885-1890.
43. Nordmann R., et al. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic. Biol. Med. 1992, 12:219-240.
44. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999, 49:6853-6866.
45. Polavarapu R., et al. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27:1317-1323.
46. Reddy B.S., et al. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res. 1997, 57:420-425.
47. Reitman S., Frankel S.A. Colorimetric method for the determination of serum oxaloacetate and glutamic pyruvate transaminases. Am. J. Clin. Pathol. 1957, 28:56-66.
48. Rouach H., et al. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997, 25:351-355.
49. Schmidt K.N., et al. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NFκ-B. Biol. Chem. 1995, 2:13-22.
50. Schreck R., et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFk-·B transcription factor and HIV-1. E. M. B. O. J. 1991, 10:2247-2258.
51. Schulze-Osthoff K., et al. Oxidative stress and signal transduction. Int. J. Vitam. Nutr. Res. 1997, 67:336-342.
52. Shaw S., et al. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation. Dig. Dis. Sci. 1983, 28:585-589.
53. Song Z., et al. S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice small star, filled. J. Nutr. Biochem. 2003, 14:591-597.
54. Stark M.J., et al. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett. 1995, 96:15-21.
55. Stayrook K.R., et al. Induction of the apoptosis promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 1997, 18:1655-1658.
56. Jahangir T., Sultana S. Perillyl alcohol protects against Fe-NTA-induced nephrotoxicity and early tumor promotional events in rat experimental model. eCAM 2007, 4:439-445.
57. Uesugi T., et al. Delivery of I-kappa-B suppressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 2001, 34:1149-1157.
58. Videla L.A., Valenzuela A. Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications. Life Sci. 1982, 3:2395-2407.
59. Wagner K.H., Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann. Nutr. Metab. 2003, 47:95-106.
60. Wright J.R., et al. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 1981, 206:296-304.
61. Wu G., et al. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134:489-492.
62. Yin M., et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999, 117:942-952.